|
Volumn 20, Issue 7, 2010, Pages 689-695
|
Drosophila as a novel therapeutic discovery tool for thyroid cancer.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PROTEIN RET;
ANIMAL;
DISEASE MODEL;
DROSOPHILA;
DRUG DEVELOPMENT;
DRUG EFFECT;
EXPERIMENTAL NEOPLASM;
GENETICS;
HUMAN;
MEDULLARY CARCINOMA;
METABOLISM;
METASTASIS;
METHODOLOGY;
NEUROFIBROMATOSIS;
PERSONALIZED MEDICINE;
REVIEW;
SIGNAL TRANSDUCTION;
SIPPLE SYNDROME;
THYROID NODULE;
THYROID TUMOR;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, MEDULLARY;
DISEASE MODELS, ANIMAL;
DROSOPHILA;
DRUG DISCOVERY;
HUMANS;
INDIVIDUALIZED MEDICINE;
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A;
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B;
NEOPLASMS, EXPERIMENTAL;
PROTO-ONCOGENE PROTEINS C-RET;
SIGNAL TRANSDUCTION;
THYROID NEOPLASMS;
THYROID NODULE;
|
EID: 78349235095
PISSN: None
EISSN: 15579077
Source Type: Journal
DOI: 10.1089/thy.2010.1637 Document Type: Review |
Times cited : (26)
|
References (0)
|